Masaru Konishi1, Yuki Takeuchi2, Nobuki Imano2, Katsumaro Kubo2, Ikuno Nishibuchi2, Yuji Murakami2, Kiichi Shimabukuro3, Pongsapak Wongratwanich3, Naoya Kakimoto3, Yasushi Nagata3. 1. Department of Oral and Maxillofacial Radiology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan. mkonishi@hiroshima-u.ac.jp. 2. Department of Radiation Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan. 3. Department of Oral and Maxillofacial Radiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.
Abstract
OBJECTIVE: This study aimed to retrospectively evaluate the radiation dose and complications in soft tissue and mandible caused by 198Au grain brachytherapy alone or the combination with other modalities in patients with the cancer of the floor of the mouth. MATERIALS AND METHODS: Twelve patients with T1 (n = 5) and T2 (n = 7) squamous cell carcinoma of the floor of the mouth, who were treated with 198Au grain brachytherapy alone (n = 5) or the combination of external beam radiotherapy (EBRT) and/or chemotherapy and 198Au grain brachytherapy (n = 7) from January 2005 to December 2016, were included. The relationships between the radiation dose and the complications of the soft tissue or mandible were investigated. RESULTS: Seven of 12 patients had died. Of these 7 patients, one with T1 and 2 with T2 had died of the causes related to the cancer of the floor of the mouth. Two with T1 and 2 with T2 had died of other diseases. Two patients had grade 2 complications of the soft tissue and mandible. These patients were treated by the combination of EBRT and/or chemotherapy and 198Au grain brachytherapy and irradiated with 123 or 139 Gy in total dose, respectively. And one of these patients was treated by the chemotherapy in addition to EBRT. CONCLUSION: Our study showed that the combination of EBRT and 198Au grains brachytherapy for the floor of the mouth cancer patients might be associated with risks of developing complications of soft tissue ulcer and mandibular bone necrosis.
OBJECTIVE: This study aimed to retrospectively evaluate the radiation dose and complications in soft tissue and mandible caused by 198Au grain brachytherapy alone or the combination with other modalities in patients with the cancer of the floor of the mouth. MATERIALS AND METHODS: Twelve patients with T1 (n = 5) and T2 (n = 7) squamous cell carcinoma of the floor of the mouth, who were treated with 198Au grain brachytherapy alone (n = 5) or the combination of external beam radiotherapy (EBRT) and/or chemotherapy and 198Au grain brachytherapy (n = 7) from January 2005 to December 2016, were included. The relationships between the radiation dose and the complications of the soft tissue or mandible were investigated. RESULTS: Seven of 12 patients had died. Of these 7 patients, one with T1 and 2 with T2 had died of the causes related to the cancer of the floor of the mouth. Two with T1 and 2 with T2 had died of other diseases. Two patients had grade 2 complications of the soft tissue and mandible. These patients were treated by the combination of EBRT and/or chemotherapy and 198Au grain brachytherapy and irradiated with 123 or 139 Gy in total dose, respectively. And one of these patients was treated by the chemotherapy in addition to EBRT. CONCLUSION: Our study showed that the combination of EBRT and 198Au grains brachytherapy for the floor of the mouth cancer patients might be associated with risks of developing complications of soft tissue ulcer and mandibular bone necrosis.
Authors: Angela T T Wong; Stephen Y Lai; G Brandon Gunn; Beth M Beadle; Clifton D Fuller; Martha P Barrow; Theresa M Hofstede; Mark S Chambers; Erich M Sturgis; Abdallah Sherif Radwan Mohamed; Jan S Lewin; Katherine A Hutcheson Journal: Oral Oncol Date: 2017-01-21 Impact factor: 5.337
Authors: Dominic H Moon; Sung Ho Moon; Kyle Wang; Mark C Weissler; Trevor G Hackman; Adam M Zanation; Brian D Thorp; Samip N Patel; Jose P Zevallos; Lawrence B Marks; Bhishamjit S Chera Journal: Oral Oncol Date: 2017-07-16 Impact factor: 5.337
Authors: K Shimizutani; Y Koseki; T Inoue; T Teshima; S Furukawa; K Kubo; H Fuchihata; N Masaki; H Ikeda; Y Tanaka Journal: Strahlenther Onkol Date: 1995-01 Impact factor: 3.621
Authors: Chiaojung Jillian Tsai; Theresa M Hofstede; Erich M Sturgis; Adam S Garden; Mary E Lindberg; Qingyi Wei; Susan L Tucker; Lei Dong Journal: Int J Radiat Oncol Biol Phys Date: 2012-07-12 Impact factor: 7.038